Skip to Content

Tag: Infusion drugs

Also Noted

OIG tells CMS again: Switch to ASP for infusion drugs

September 8, 2016HME News Staff

WASHINGTON - The Office of Inspector General in a new report reiterates its concerns that, unlike most Part B drugs, Medicare payment amounts for DME infusion drugs are still based on average wholesale prices from 2003. Three years ago, the OIG published a report recommending changes to Medicare payments for DME infusion drugs; however, CMS has continued to reimburse for these drugs at prices that are unrelated to the amounts providers pay to acquire them. The OIG is concerned that paying for the...

Infusion drugs, Office of Inspector General (OIG), Report

Read Full Articlered right arrow icon